Hospital Universitario Virgen de las Nieves-ko ikertzaileekin lankidetzan egindako argitalpenak (52)

2024

  1. Analyzing diagnostic and treatment wait times for lung cancer Patients: Key insights from a provincial registry study

    Lung Cancer, Vol. 194

  2. Matrix Metalloproteinases and Their Inhibitors as Potential Prognostic Biomarkers in Head and Neck Cancer after Radiotherapy

    International Journal of Molecular Sciences, Vol. 25, Núm. 1

  3. Resectable Non-Small Cell Lung Cancer Heterogeneity and Recurrence Assessed by Tissue Next-Generation Sequencing Genotyping and Circulating Tumor Cell EZH2 Characterization

    Archivos de Bronconeumologia

2023

  1. Associations of accumulated persistent organic pollutants in breast adipose tissue with the evolution of breast cancer after surgery

    Science of the Total Environment, Vol. 897

  2. Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer

    Biomarker Research

  3. Cerebellopontine angle meningiomas: LINAC stereotactic radiosurgery treatment

    Neurocirugia, Vol. 34, Núm. 6, pp. 283-291

  4. Circulating tumor cells in cancer-risk populations as a cancer interception tool

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 113-129

  5. Clinical Outcomes of First-line Therapies for Advanced Non-Small Cell Lung Cancer: A Systematic Review of Trials Published Between 2010 and 2020

    American journal of clinical oncology, Vol. 46, Núm. 10, pp. 433-438

2022

  1. A Novel, Quick, and Reliable Smartphone-Based Method for Serum PSA Quantification: Original Design of a Portable Microfluidic Immunosensor-Based System

    Cancers, Vol. 14, Núm. 18

2021

  1. Adipose Tissue Redox Microenvironment as a Potential Link between Persistent Organic Pollutants and the 16-Year Incidence of Non-hormone-Dependent Cancer

    Environmental Science and Technology, Vol. 55, Núm. 14, pp. 9926-9937

  2. Analyzing the clinical benefit of newer therapies for advanced or metastatic non-small-cell lung cancer: application of the ESMO-magnitude of clinical benefit scale v1.1

    Acta Oncologica, Vol. 60, Núm. 9, pp. 1225-1232

  3. The role of multimorbidity in short-term mortality of lung cancer patients in Spain: a population-based cohort study

    BMC Cancer, Vol. 21, Núm. 1

2020

  1. BNCT research activities at the Granada group and the project NeMeSis: Neutrons for medicine and sciences, towards an accelerator-based facility for new BNCT therapies, medical isotope production and other scientific neutron applications

    Applied Radiation and Isotopes, Vol. 165

  2. Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients

    Scientific Reports, Vol. 10, Núm. 1

  3. From precision medicine to imprecision medicine through limited diagnostic ability to detect low allelic frequency mutations

    Translational Lung Cancer Research, Vol. 9, Núm. 2, pp. 180-183

  4. Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome

    Cells, Vol. 9, Núm. 9

  5. The efficacy of three-dimensional conformal radiation therapy on pain and quality of life in patients with painful bone metastases: A prospective study

    Croatian Medical Journal, Vol. 61, Núm. 3, pp. 215-222

2019

  1. Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents

    Cells, Vol. 8, Núm. 11

  2. Patient, tumor, and healthcare factors associated with regional variability in lung cancer survival: a Spanish high-resolution population-based study

    Clinical and Translational Oncology, Vol. 21, Núm. 5, pp. 621-629

2018

  1. Surgery versus stereotactic radiotherapy for people with single or solitary brain metastasis

    Cochrane Database of Systematic Reviews, Vol. 2018, Núm. 8